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The marine bacterium Vibrio vulnificus is a human pathogen that can spontaneously switch between virulent
opaque and avirulent translucent phenotypes. Here, we document an additional form, the rugose variant, which
produces copious biofilms and which may contribute both to pathogenicity of V. vulnificus and to its survival
under adverse environmental conditions.
Vibrio vulnificus is a marine bacterium that can cause human
disease and has been implicated as the cause of over 95% of
the deaths related to seafood consumption in the United States
(13, 25). Infection usually occurs through the ingestion of raw
oysters or by contact of an open wound with contaminated
seawater. Susceptible individuals include those with liver dis-
ease, immune dysfunction, or elevated serum iron levels. When
a susceptible individual consumes raw oysters contaminated
with V. vulnificus, the result can be a rapidly fulminating sep-
ticemia, with mortality occurring in over 50% of cases (13, 25).
Some V. vulnificus isolates produce a polysaccharide capsule
(3) which gives the colonies a smooth, mucoid, opaque phe-
notype. It has been reported that the capsule is a major viru-
lence factor, presumably protecting the bacterium from the
host immune system (23, 32). In culture, many opaque (O)
strains spontaneously produce translucent (T) variants (28,
35). Opaque strains have been shown to be virulent in a mouse
model, while translucent strains were avirulent in this model
(23, 32, 35). Several studies have shown that capsular polysac-
charide (CPS) expression varies between opaque and translu-
cent strains as well as among different translucent strains (i.e.,
suggesting there are different degrees of translucence) (28, 29,
32). Transposon insertions have been shown to produce com-
pletely acapsular translucent strains (28, 29, 35).
Opaque strains of V. vulnificus have been reported to switch
spontaneously to the translucent phenotype at frequencies of
105 to 104 when the cells were grown in rich medium (12, 29,
32). If grown in a peptone-based yet more-defined medium,
the switch occurs at a higher frequency, with over 60% of the
colonies exhibiting the translucent phenotype (23). The reverse
switch, from translucent to opaque, has been reported to occur
at frequencies of 9.2  103 (29), less than 104 (32), or not at
all (12, 23). We have previously observed that opaque strains
will spontaneously yield translucent variants much more often
than the reverse. However, the translucent-to-opaque switch
did occur on rare occasions when strains were routinely sub-
cultured in heart infusion broth at 37°C and then left to stand
at room temperature for several days before plating and incu-
bation of plates at 37°C (unpublished results).
Vibrio cholerae, the etiological agent of cholera, is a close
relative of V. vulnificus. Although the O1 strains of V. cholerae
produce no CPS, they have been responsible for the first six
pandemics of cholera. The current, seventh pandemic has been
caused not only by O1 strains but also by O139 strains, which
do produce CPS (19). In addition to the encapsulated and
nonencapsulated smooth phenotypes, V. cholerae exhibits a
third colony phenotype, rugose. First identified in the late
1930s (27), rugose (R) variants arise in both O1 and non-O1 V.
cholerae strains and are wrinkled and dry compared to the
smooth, mucoid phenotypes of the nonrugose strains. Typi-
cally, rugose variants are obtained following growth in minimal
medium or under prolonged starvation conditions. Rugose
variants have been shown to form well-developed biofilms and
to be more resistant than the smooth forms to chlorine, hy-
drogen peroxide, UV light, complement activity in human se-
rum, and osmotic stress (1, 18, 20, 22, 26, 31). It was suggested
that the rugose phenotype may allow V. cholerae to survive
under adverse environmental conditions (1, 26, 31).
Previously, we observed during subculturing of opaque and
translucent strains of V. vulnificus that each could yield the
other phenotype, although frequencies of these switching
events were not determined. Here, we undertook a more com-
prehensive analysis to determine the frequency of conversion
between opaque and translucent phase variants. Under care-
fully controlled conditions, we found high frequencies of con-
version from the opaque to the translucent phenotype and also
of translucent isolates switching to opacity. More significantly,
our analysis revealed a new phenotypic form of V. vulnificus,
the rugose variant. Further characterization of this variant
revealed it to be relatively nonmotile, more resistant to serum
killing than its parental opaque or translucent version, and
capable of producing copious amounts of biofilm.
Appearance of a rugose phenotype for V. vulnificus. The
opaque parental strain 1003(O), three spontaneous translucent
derivatives [AZ(T), BG(T1), and BG(T2)], as well as two pre-
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viously described (24, 35) transposon-induced translucent
strains [ABZ1(T) and GMB4(T)] (Fig. 1 and Table 1) were
subjected to culture conditions that allowed switching to the
alternate phenotype. In an adaptation of a previously de-
scribed procedure (15), V. vulnificus strains were tested for
phenotypic switching by using heart infusion broth and heart
infusion agar plates, both supplemented to 2% NaCl (HI).
Briefly, 10-ml HI broth cultures were started from isolated
colonies and, following overnight incubation at 34 to 35°C with
shaking at 200 rpm, the first passage was started by diluting the
original culture 1:100 into fresh broth followed by overnight
incubation as before. Daily passages were continued for 5 to 6
days (one cycle), the final passage was serially diluted and
plated on HI agar, and the plates were incubated at 30°C
overnight, whereupon colonies and their phenotypes were enu-
merated. On the same day as the plating, another passage was
made in case there was no phenotypic switching. In that case,
daily passages were continued for another 5- to 6-day cycle,
followed by dilutions and platings as before. A third cycle of
passaging and plating was performed as necessary, and results
were recorded as percentages [100  (number of colonies
showing a particular phenotype divided by the total number of
colonies in all cycles)].
The results of three independent switching assays are given
as the average percentage of each resulting phenotype (Table
2). Not only did the opaque strain 1003(O) often switch to the
translucent phenotype but, as with most of the other strains, it
also produced a small, wrinkled, and dry colony type (Fig. 2)
FIG. 1. Relationship of phase variants used in this study. All first-
level variants were derived directly from the Louisiana clinical isolate,
V. vulnificus 1003(O). O, opaque; T, translucent; R, rugose.
TABLE 1. Bacterial strains used in this study
Strain Isolation and characterizationa Reference(s) or source
V. vulnificus 1003
1003(O) Wound isolate, opaque, encapsulated, virulent; designated as wild
type, smooth; CPS serotype 9, LPS serotype unk.; Colr
16
BG(R) Spontaneous rugose derivative of 1003(O), dry, wrinkled This study
BG(T1) Spontaneous translucent derivative of 1003(O), smooth This study
BG(T2) Spontaneous highly translucent derivative of BG(T1), smooth This study
AZ(T) Spontaneous highly translucent derivative of 1003(O), avirulent,
smooth, previously 1003(T)
35
ABZ1(T) Translucent, avirulent; defective in capsule expression due to
mini-Tn10 insertion in the wcvA gene of 1003(O), smooth;
Kanr
24, 35
ABZ1(R) Spontaneous rugose derivative of ABZ1(T), dry, wrinkled; Kanr This study
GMB4(T) Translucent, avirulent; mini-Tn10 insertion in ORF4 of 1003(O)
super-integron region, smooth; previously ABZ44(T); Kanr
24, 34
GMB4(R) Spontaneous rugose derivative of GMB4(T), dry, wrinkled; Kanr This study
GMB4(O) Spontaneous opaque derivative of GMB4(T), smooth; Kanr This study
V. vulnificus
1005(O) Blood isolate, opaque, smooth; CPS serotype 1, LPS serotype 3 16
1005(R) Spontaneous rugose derivative of 1005(O), dry, wrinkled This study
1007(O) Blood isolate, opaque, smooth; CPS serotype 4, LPS serotype O1 16
1007(R) Spontaneous rugose derivative of 1007(O), dry, wrinkled This study
1014(O) Blood isolate, opaque, smooth; CPS serotype 3, LPS serotype 2 16
1014(R) Spontaneous rugose derivative of 1014(O), dry, wrinkled This study
96-7-155(O) Eel isolate, opaque, smooth; CPS serotype 9, LPS serotype unk. Laboratory collection
96-7-155(R) Spontaneous rugose derivative of 96-7-155(O), dry, wrinkled This study
a Colr, colistin resistance; Kanr, kanamycin resistance; LPS, lipopolysaccharide; unk., unknown.
TABLE 2. Phenotypic switching of V. vulnificus 1003 phase variants
Parent straina







1003(O) 55.2 (23.0) 30.6 (16.2) 13.0 (3.0)
BG(T1) 17.3 (12.4) 74.7 (15.9) 5.8 (2.9)
BG(T2) 1.7 (0.9) 94.3 (2.1) 3.8 (2.2)
AZ(T) 0.5 (0.4) 98.1 (1.7) 0 (0.0)
ABZ1(T) 0 (0.0) 78.2 (16.0) 18.2 (12.8)
GMB4(T) 7.9 (7.7) 79.8 (10.5) 8.3 (5.5)
BG(R), 30°C 15.8 (3.2) 0.1 (0.04) 53.8 (2.8)
BG(R), 37°C 26.3 (15.5) 0 (0.0) 53.1 (21.8)
ABZ1(R), 30°C 0 (0.0) 42.9 (21.0) 42.0 (13.0)
ABZ1(R), 37°C 0 (0.0) 3.7 (3.7) 94.2 (5.0)
a O, opaque; T, translucent; R, rugose. Switching assays were conducted for
one to three cycles of culture passaging and plating as described in the text, with
O and T broth cultures incubated at 34 to 35°C and plates incubated at 30°C; R
broth cultures and plates were incubated at either 30 or 37°C as indicated.
b The total percentage of colonies for a given strain does not equal 100 because
some colonies were sectored while others were of an intermediate phenotype.

























































that resembled the rugose phenotype reported for V. cholerae
(18, 20, 26, 31) and other bacterial species (4, 8). Translucent
strains meanwhile varied considerably in their conversion to
the alternate phenotypes. Of the spontaneously isolated
strains, BG(T1) produced opaque colonies at a frequency 10-
fold greater than that of its more highly translucent derivative,
BG(T2). Strain AZ(T), the most translucent of the spontane-
ous translucent strains used here, produced 35-fold fewer
opaque colonies than BG(T1) and never produced a rugose
colony during any of the three switching assays. AZ(T) has
been shown to have a chromosomal rearrangement involving
an insertion sequence (24) when compared to 1003(O). While
it is possible that this rearrangement may have rendered the
strain unable to yield a rugose phenotype, it is also possible
that, as this strain produces opaque variants only rarely, it may
also produce rugose variants, but at a low level undetected in
our switching assay.
Two previously described translucent variants of parental
strain 1003(O) that were isolated following transposon mu-
tagenesis (24, 35) were also examined for their switching fre-
quencies. The first of these, ABZ1(T), contains an insertion in
a gene (wcvA) that is essential for capsule production and, as
expected, it showed no conversion to opacity (Table 2). It did,
however, yield rugose colonies, which demonstrates that the
rugose phenotype in V. vulnificus can occur independently
from capsule production. In contrast, strain GMB4(T), which
contains an insertion in ORF4 of the super-integron region of
the V. vulnificus genome (6), produced not only a rugose form
but, surprisingly, also converted to the opaque phenotype. An
isolated opaque derivative of GMB4(T) [i.e., GMB4(O)] re-
tained both the kanamycin resistance and the mutant ORF4
PCR product that are characteristic of the translucent parent
(data not shown). Also, introduction of an uninterrupted ver-
sion of ORF4 on a plasmid into GMB4(T) did not restore the
opaque phenotype of the original parental strain (data not
shown). Based on these data, it appears that GMB4(T) arose
spontaneously from 1003(O) and coincidentally acquired the
transposon during the original transposon mutagenesis exper-
iments (34).
The 16S rRNA genes from rugose variants isolated from
both opaque and translucent parental types were amplified by
PCR using previously described primers (21), the amplified
products were subjected to automated sequencing, and the
resulting sequences were used in BLASTN (2) searches of
relevant databases. The submitted sequences (GenBank acces-
sion numbers AY676130, AY676132, and AY676133) showed
greatest identity (97 to 99%) to 16S rRNA genes from known
V. vulnificus strains (data not shown).
Characterization of V. vulnificus rugose variants. Because
rugose isolates of V. cholerae show decreased motility relative
to their smooth counterparts (1), rugose strains of V. vulnificus
were tested for their motility characteristics relative to their
opaque or translucent parents. Following inoculation from col-
onies onto HI plates containing 0.3% agar and incubation for
6 h at 30°C, both BG(R) and ABZ1(R) showed much lower
motility than their respective opaque [1003(O)] and translu-
cent [ABZ1(T)] parental strains, which produced wide motility
zones of similar sizes (Fig. 3). Interestingly, ABZ1(R) consis-
tently demonstrated a greater-than-twofold motility increase
over the opaque-derived BG(R) (Fig. 3), and similar results
were observed for rugose isolates derived from other translu-
cent parents (data not shown). Despite their decreased motility
in 0.3% agar, both BG(R) and ABZ1(R) cells were observed
by transmission electron microscopy to possess a polar flagel-
lum and under phase-contrast microscopy to actively swim in
phosphate-buffered saline (data not shown). The presence of a
polar flagellum for rugose isolates is similar to the findings for
rugose V. cholerae as described by Ali et al. (1).
Rugose V. vulnificus isolates BG(R) and ABZ1(R) were
analyzed for their resistance to complement-mediated serum
killing by exposing cells grown in broth culture to normal
human serum (NHS; Sigma) at 37°C as described previously
(5). Each culture was started from a representative colony of a
given phenotype, and the experiments were conducted twice
with the averages reported. As expected, the parental opaque
strain 1003(O) showed much greater resistance to serum than
the translucent parent ABZ1(T). Specifically, 1003(O) demon-
strated serum resistance of approximately 57% (standard error
FIG. 2. V. vulnificus 1003 phase variants. All colonies were grown on HI agar plates for 24 to 48 h at 30°C and viewed with a dissecting
microscope. (A) Opaque (1), translucent (2), and rugose (3) colonies. (B) A rugose colony at higher magnification.

























































[SE], 11.5%) (i.e., percent survival of cells exposed to NHS
relative to the survival of cells exposed to heat-inactivated
NHS), while ABZ1(T) was over 300-fold less resistant at
0.18% (SE, 0.08%) survival. While serum resistance relative to
that of the specific parents appeared slightly elevated for rug-
ose isolates BG(R) (87%; SE, 35.3%) and ABZ1(R) (1.0%;
SE, 0.6%), the latter translucent-derived rugose isolate was
still more sensitive by over 50-fold compared to the opaque
strain 1003(O) and by over 80-fold compared to the opaque-
derived rugose derivative BG(R). Taken together, the motility
and serum resistance data demonstrate that although rugose
isolates derived from opaque and translucent parents appear
identical in colony morphology, they show significant differ-
ences with respect to other characteristics.
To demonstrate that the rugose phenotype is not unique to
V. vulnificus 1003 and its derivatives, 26 other V. vulnificus
strains, from environmental and clinical sources, were tested
qualitatively for the ability to form rugose colonies. Upon
growth overnight in HI broth at 34 to 35°C followed by streak-
ing onto HI agar and incubation of plates at 30°C overnight,
the rugose phenotype was shown by three Louisiana clinical
isolates (1005, 1007, and 1014) and one eel isolate (96-7-155)
from Denmark (data not shown). The parent phenotype of
these four strains is opaque. The other 22 strains produced
only opaque or translucent colonies in this shortened assay.
Rugose V. vulnificus produces copious biofilms. When inoc-
ulated into broth and incubated at 30°C with shaking, all V.
vulnificus 1003 phase variants grew suspended in the broth,
although rugose isolates formed an aggregate ring at the air-
broth-glass interface. When the broth was incubated statically
at 30°C (Fig. 4), opaque and translucent strains grew sus-
pended in the broth while rugose variants formed a pellicle at
the air-broth interface as well as the aggregate ring and did not
grow in suspension; rather, aggregates formed at the pellicle,
sank to the bottom of the tube, and accumulated there while
the broth remained clear. The aggregate ring and pellicle did
not form when rugose isolates were incubated at 37°C (data
not shown).
The aggregate ring produced by rugose strains of V. vulnifi-
cus at the air-broth-glass interface in culture tubes resembled
biofilms produced by V. cholerae rugose variants (31). Biofilms
produced by V. vulnificus phase variants that were grown in
glass culture tubes at 30°C statically for 48 h were quantified by
staining with crystal violet, resuspending the stained biofilms in
dimethyl sulfoxide, and measuring the absorbance of the ex-
tracted stain at 570 nm (1, 33). Rugose variants produced
significantly more biofilm than did opaque or translucent
strains (Table 3). Strains BG(R), ABZ1(R), and GMB4(R)
produced 16 (P  0.005), 20 (P  0.05), and 17 (P  0.0005)
times, respectively, the amount of biofilm produced by the
opaque strain 1003(O). Meanwhile, 1003(O) produced rela-
tively minimal biofilms, which appeared to be consistently
greater than those produced by its translucent derivatives; in
most cases, the difference in biofilm formation between
FIG. 3. Swimming motility of V. vulnificus 1003 strains. Motility
agar plates were inoculated from isolated colonies of each phase vari-
ant and incubated at 30°C for 6 h. Thirty-five colonies of each variant
were tested.
FIG. 4. Distribution of V. vulnificus 1003 phase variants in broth
culture. The rugose variant BG(R) (tube 2) forms a pellicle and ag-
gregate ring after static growth in HI broth for 24 h at 30°C. As cells
accumulate in the pellicle, aggregates break off and sink to the bottom
of the tube. Both the 1003(O) (tube 1) and AZ(T) (tube 3) strains grow
dispersed in the broth and do not form a pellicle or aggregates.
TABLE 3. Biofilm production by V. vulnificus 1003 phase variants
Strain Absorbance at570 nm (SE)a
Relative biofilm
productionb
1003(O) 0.279 (0.041) 1.00
AZ(T) 0.140 (0.019) 0.51
ABZ1(T) 0.163 (0.045) 0.58
GMB4(T) 0.191 (0.033) 0.68
BG(R) 4.429 (0.528) 15.87
ABZ1(R) 5.602 (1.322) 20.19
GMB4(R) 4.857 (0.421) 17.41
a Absorbance is the average of triplicate measurements obtained in biofilm
tube assays as described in the text. Absorbance values of incubated H1 broth
also were measured and subtracted from the experimental sample values to
correct for background.
b Relative biofilm production is calculated relative to that produced by
1003(O).

























































opaque and translucent strains was not statistically significant
(Table 3).
To confirm and extend the results from the tube assay, V.
vulnificus phase variants were grown statically in HI broth in
six-well culture plates at 30°C for up to 6 h, and the resulting
biofilms that formed at the air-broth interface were harvested
by their attachment upon contact to collodion-coated glass
coverslips as described previously (10) and viewed by differen-
tial interference contrast microscopy. Figure 5 shows that while
the rugose strains BG(R) and ABZ1(R) (Fig. 5B and D, re-
spectively) produced a thick pellicle and adhered to the collo-
dion-coated coverslip as a biofilm, their respective parental
strains 1003(O) and ABZ1(T) (Fig. 5A and C, respectively) did
not produce pellicles and adhered as individual cells. Com-
pared to the quantitative results for the tube assay, the differ-
ence in biofilm formation between the opaque and translucent
strains here appears to be greater; however, it is noteworthy
that while the earlier assay involved staining biofilms that had
adhered to glass tubes at the air-broth interface, the latter
method involved capturing previously formed biofilms upon
contact with collodion-coated coverslips.
Production of biofilms has been reported previously for V.
vulnificus (11, 14, 17). In particular, a recent study reported
that various translucent strains of V. vulnificus produced over
three times more biofilm than their parent opaque strain (11).
Although the basis for the apparent discrepancy between that
study and ours remains undetermined, it is possible that strain
differences and/or differences in the media and experimental
protocols used for biofilm formation may be contributing fac-
tors. Previously, a significant difference in biofilm production
was observed for different smooth strains of V. cholerae O1 El
Tor (30).
Switching of rugose forms back to opaque and translucent
colony forms. V. vulnificus strains have been grown routinely at
37°C in our laboratory, and no rugose phenotype was previ-
ously observed. This included switching assays involving
opaque and translucent isogenic pairs, which were performed
similarly to ours, except that alkaline peptone water minimal
FIG. 5. Differential interference contrast micrographs of V. vulnificus 1003 biofilms collected with a collodion-coated coverslip. Fresh medium
was inoculated 1:100 into six-well plates from the appropriate overnight cultures, and the resulting cultures were incubated statically for up to 6 h
at 30°C. Biofilms that formed at the air-broth interface were harvested upon contact with collodion-coated coverslips. Each strain was grown in
triplicate cultures, and the assay was conducted at least twice for each strain. (A) 1003(O); (B) BG(R); (C) ABZ1(T); (D) ABZ1(R). Bars, 10 m.

























































medium and a consistent temperature of 37°C were used for all
culture and plate incubations (15). In our study, the rugose
variants appeared when HI broth cultures were incubated at
temperatures below 37°C and plates were incubated at 30°C.
To examine the persistence of rugose isolates at different tem-
peratures, strains BG(R) and ABZ1(R) were subjected to
switching assays where all inoculations, passages, and platings
were done as described with incubations at either 30 or 37°C
throughout the assays. The results (Table 2) showed that sig-
nificant numbers of the opaque-derived rugose isolate BG(R)
could persist at both 30 and 37°C. Switching of BG(R) back to
opaque variants was also observed while, interestingly, conver-
sion to a translucent form was barely detectable (at 30°C) or
was not seen at all (at 37°C). Persistence of ABZ1(R), the
rugose derivative of the acapsular transposon mutant
ABZ1(T), was also detected at 30°C and even more so at 37°C.
As expected, no switching back to the opaque phenotype was
observed for ABZ1(R), while conversion to translucence was
observed at both temperatures. Consistent with their new phe-
notypes, opaque and translucent derivatives of rugose strains
obtained during these assays showed increased motility and
lost the ability to form pellicles during static growth in broth
(data not shown).
Here, we have described a new phenotypic version of V.
vulnificus, the rugose variant, which is produced at high fre-
quencies from both opaque and translucent parental strains
when they are cultured repeatedly at temperatures below 37°C
and which, once formed, persists even at 37°C. Rugose cells are
capable of forming prodigious biofilms, and rugose isolates
derived from the opaque parent were highly resistant to the
complement-mediated killing of human serum. Based on these
characteristics, the rugose form of V. vulnificus may play an
important role not only in pathogenesis within the human host
but also in survival within the cooler temperatures of its natural
marine environment. Biofilm formation in the latter case may
allow the organism to persist under conditions that are often
nutritionally deficient or are otherwise unfavorable (7, 9).
Previous studies of phase variation in V. vulnificus involved
inoculating rich medium with a single colony, incubating it
overnight, and plating dilutions the next day. None of these
studies reported the existence of a rugose phenotype (12, 23,
29, 32). Most of the studies that resulted in isolation of the V.
cholerae rugose variant involved incubating starvation media
cultures for extended times (18, 26, 31); however, a high-
frequency rugose-producing strain of V. cholerae was isolated
after only 24 to 48 h of incubation (1). In our study, the
aggregate ring appeared in the culture tubes as early as the
third day of the incubation cycle. Our method of inoculating
rich medium and subculturing each day for a total of 5 to 6 days
before plating seems to allow not only for high-frequency
opaque and translucent phase variation, but also for high-
frequency rugose production by both opaque and translucent
strains. Though rich medium was used and cells were not
under the continuous nutritional stress of growing in starvation
medium, cultures did undergo many hours in stationary phase
each day prior to their next passage. Such nutritional depriva-
tion, though temporary, may have contributed to the observed
high frequency of switching events.
Clearly more study is needed to elucidate the mechanisms
that underlie the ability of V. vulnificus to convert between
encapsulated opaque and nonencapsulated translucent forms,
as well as to switch from these variants to the newly docu-
mented rugose form. Alteration of its morphology among
these distinct phenotypes has obvious and important conse-
quences for the ability of V. vulnificus to survive and cause
disease.
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